Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT01479907 - Lacticaseibacillus paracasei paracasei 19 + Lactiplantibacillus plantarum 2362 + Leuconostoc mesenteroides 32-77:1 + Pediococcus pentosaceus 5-33:3 + Beta-Glucan + Inulin-type fructans (ITF) / Inulin + Pectins + Resistant starch (RS) (Synbiotic Forte) vs Placebo & Surgery (to improve) (Colorectal Cancer (CRC) (after colectomy))

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

The aim of this double-blinded prospective randomized trial is to explore the potential benefits of early postoperative administration of Synbiotics to patients who have undergone colectomy for cancer. The study patients are randomized before surgery to receive either synbiotics (Synbiotics group) or placebo (Control group).

Primary outcome measures:
Assessment of gastrointestinal function-related quality of life at 1, 3 and 6 months postoperatively

Currently, no published clinical data have been found as of late 2025

…

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Welcome to meRfi Microbiome!

Navigation

Contents

AI Chat

Links